November 15, 1995Circulation
A Comparison of the Costs of and Quality of Life After Coronary Angioplasty or Coronary Surgery for Multivessel Coronary Artery Disease
Why the study?
Does percutaneous transluminal coronary angioplasty compared to coronary surgery improve clinical outcomes and reduce costs in patients with multivessel coronary artery disease?
Population
Patients with multivessel coronary artery disease
Comparison
Percutaneous transluminal coronary angioplasty vs Coronary surgery
Design
RCT, Randomized
Follow-up
3 years
Authors
Discussion
Loading...
Member takes
Implication
PTCA lowers 3-year costs versus surgery with equivalent clinical outcomes; supports its use as a cost-effective option in multivessel CAD.
Structured PICO
Does percutaneous transluminal coronary angioplasty compared to coronary surgery improve clinical outcomes and reduce costs in patients with multivessel coronary artery disease?
P
Population
Patients with multivessel coronary artery disease
I
Intervention
Percutaneous transluminal coronary angioplasty (PTCA)
C
Comparator
Coronary surgery
O
Outcome
Composite of death, Q-wave myocardial infarction, and a large reversible thallium defect at 3 yearscomposite
While initial procedural costs of PTCA are lower than coronary surgery for multivessel CAD, this cost advantage significantly narrows by 3 years due to the need for more frequent additional procedures and antianginal medications in the PTCA group.
Cite This Study
Weintraub et al. (1995) studied this question.